Facilitating matched pairing and expression of TCR chains introduced into human T cells
Top Cited Papers
Open Access
- 2 November 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (6) , 2331-2338
- https://doi.org/10.1182/blood-2006-05-023069
Abstract
Adoptive transfer of T lymphocytes is a promising treatment for a variety of malignancies but often not feasible due to difficulties generating T cells that are reactive with the targeted antigen from patients. To facilitate rapid generation of cells for therapy, T cells can be programmed with genes encoding the α and β chains of an antigen-specific T-cell receptor (TCR). However, such exogenous α and β chains can potentially assemble as pairs not only with each other but also with endogenous TCR α and β chains, thereby generating αβTCR pairs of unknown specificity as well as reducing the number of exogenous matched αβTCR pairs at the cell surface. We demonstrate that introducing cysteines into the constant region of the α and β chains can promote preferential pairing with each other, increase total surface expression of the introduced TCR chains, and reduce mismatching with endogenous TCR chains. This approach should improve both the efficacy and safety of ongoing efforts to use TCR transfer as a strategy to generate tumor-reactive T cells.Keywords
This publication has 50 references indexed in Scilit:
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 StabilityCancer Research, 2006
- αβ T-Cell Receptor Engineered γδ T Cells Mediate Effective Antileukemic ReactivityCancer Research, 2006
- Wilms' tumour gene 1 (WT1) in human neoplasiaLeukemia, 2005
- Enhanced Transgene Expression in Quiescent and Activated Human CD8+T CellsHuman Gene Therapy, 2004
- Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptorsEuropean Journal of Immunology, 2004
- Adoptive-cell-transfer therapy for the treatment of patients with cancerNature Reviews Cancer, 2003
- Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not manGene Therapy, 2002
- Folding, heterodimeric association and specific peptide recognition of a murine αβ T-cell receptor expressed in Escherichia coli 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Preferential expression of TCR Vα regions in CD4/CD8 subsets: class discrimination or co-receptor recognition?Immunology Today, 1998